Cure My Disease

Don't miss your cure!

 Log in / Sign up

New study puts omnipod 5 to the test in Real-World diabetes management

NCT ID NCT07039942

Ongoing Disease control Sponsor: Insulet Corporation Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Aug 04, 2026 · Updated 3 times

Summary

This study is testing the Omnipod 5, a tubeless insulin pump that automatically adjusts insulin delivery, in real-world settings for people with type 1 diabetes. About 304 participants aged 2 and older will use the system for the first time. Researchers will track blood sugar control, quality of life, and satisfaction over time.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Omnipod 5 Automated Insulin Delivery System (a tubeless insulin pump)
What this could lead to
If successful, this could show that the Omnipod 5 system helps people with type 1 diabetes manage their blood sugar more easily in daily life.
What could go wrong
This is an observational study, not a controlled trial, so results may not prove cause and effect. The device is already approved, so this study focuses on real-world use, not a breakthrough.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetes mellitus type 1 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETES DIABETES MELLITUS TYPE 1 DIABETES

Contacts and locations

Locations

  • APHP Hopital Avicenne

    Bobigny, 93000, France

  • APHP Hopital Robert Debré

    Paris, 75019, France

  • APHP Hôpital Bicêtre

    Le Kremlin-Bicêtre, 94270, France

  • APHP Hôpital Lariboisière

    Paris, 75010, France

  • APHP La Pitié Salpêtrière

    Paris, 75013, France

  • CH Périgueux

    Périgueux, 24000, France

  • CHRU Strasbourg

    Strasbourg, 67200, France

  • CHU Angers

    Angers, 49100, France

  • CHU Besançon - Hôpital de Jean Minjoz

    Besançon, France

  • CHU Bordeaux - Hôpital Pellegrin

    Bordeaux, 33000, France

  • CHU Bordeaux - Hôpital St-André

    Bordeaux, 33000, France

  • CHU BresCHU Brest - Hôpital de la Cavale Blanchet - Hôpital de la Cavale Blanche

    Brest, 29200, France

  • CHU Dijon - Hôpital François MitterrandCHU Dijon - Hôpital François Mitterrand

    Dijon, France

  • CHU Montpellier - Hôpital Arnaud de Villeneuve

    Montpellier, 34090, France

  • CHU Montpellier - Hôpital Lapeyronie

    Montpellier, 34090, France

  • CHU Orléans

    Orléans, 45100, France

  • Cabinet Médical Saint-Cyr sur Loire

    Saint-Cyr-sur-Loire, 37540, France

  • Centre Hospitalier Sud Francilien

    Corbeil-Essonnes, 91100, France

  • Diab-eCare

    Lyon, 69008, France

  • Fondation Ambroise Paré - Hôpital Européen de Marseille

    Marseille, France

  • GH La Rochelle-Ré-Aunis - Hôpital Saint Louis

    La Rochelle, 17019, France

  • Hôpital Femme Mère Enfant

    Bron, 39500, France

  • Hôpital NECKER

    Paris, 75015, France

  • Institut de Diabétologie et de Nutrition du Centre

    Mainvilliers, 28300, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.